Clinical Trial Update: Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Nirogacestat in premenopausal females with desmoid-type fibromatosis is currently recruiting. The study aims to further eval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• Nirogacestat (nirogacestat)

Snippet

Sponsor: SpringWorks Therapeutics, Inc. | Conditions: Desmoid Tumor, Aggressive Fibromatosis | Phase 4 | Status: RECRUITING